Management of a Patient with Cardiovascular Disease Should Include Assessment of Primary and Secondary Immunodeficiencies: Part 1—Primary Immunodeficiencies.

Autor: Napiórkowska-Baran, Katarzyna, Doligalska, Agata, Drozd, Magdalena, Czarnowska, Marta, Łaszczych, Dariusz, Dolina, Marcin, Szymczak, Bartłomiej, Schmidt, Oskar, Bartuzi, Zbigniew
Předmět:
Zdroj: Healthcare (2227-9032); Oct2024, Vol. 12 Issue 19, p1976, 15p
Abstrakt: Background: Cardiovascular diseases are some of the most prevalent chronic diseases that generate not only high social but also economic costs. It is becoming increasingly crucial to take into account inborn errors of immunity (IEIs, formerly known as primary immunodeficiencies (PIDs)) and secondary immunodeficiencies (SIDs) in the diagnostic and therapeutic management of cardiac patients. The number of diseases classified as IEIs is on the rise, with a current total of 485. It is essential to pay attention not only to already confirmed conditions but also to symptoms suggestive of immunodeficiencies. Objectives: The aim of this article is to present IEIs with cardiovascular symptoms that may cause or exacerbate cardiovascular disease, as well as diagnostic and therapeutic procedures. Results: It is becoming increasingly evident that immunodeficiencies can be responsible for certain cardiovascular conditions, their hastened progression, and difficulties in their control. Conclusions: Early detection of deficiencies improves not only the quality and longevity of patients, but also allows for better control of cardiovascular diseases and even prevention of their occurrence. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index